Dnca Finance Grows Stake in Veeva Systems Inc. $VEEV

Dnca Finance boosted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 16.8% during the 3rd quarter, Holdings Channel reports. The firm owned 38,525 shares of the technology company’s stock after buying an additional 5,550 shares during the period. Dnca Finance’s holdings in Veeva Systems were worth $11,477,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the business. Wellington Management Group LLP boosted its stake in Veeva Systems by 1.3% in the 3rd quarter. Wellington Management Group LLP now owns 1,466,827 shares of the technology company’s stock worth $436,982,000 after purchasing an additional 18,349 shares during the period. NorthRock Partners LLC boosted its position in shares of Veeva Systems by 44.0% during the third quarter. NorthRock Partners LLC now owns 2,522 shares of the technology company’s stock worth $751,000 after acquiring an additional 771 shares during the last quarter. Arrowpoint Investment Partners Singapore Pte. Ltd. purchased a new position in Veeva Systems during the third quarter valued at $540,000. Comerica Bank grew its stake in Veeva Systems by 7.9% during the third quarter. Comerica Bank now owns 33,178 shares of the technology company’s stock valued at $9,884,000 after acquiring an additional 2,442 shares in the last quarter. Finally, Perbak Capital Partners LLP bought a new stake in Veeva Systems in the 3rd quarter valued at $881,000. 88.20% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total transaction of $231,430.00. Following the completion of the transaction, the insider owned 23,204 shares in the company, valued at $5,370,101.72. The trade was a 4.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 10.30% of the stock is currently owned by insiders.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva agreed to buy AI brand‑engagement platform Ostro for $100M to add AI-powered customer engagement tools for life‑sciences customers — expands Veeva’s product set and accelerates its AI strategy. Veeva Acquires Ostro to Expand AI-Powered Engagement in Life Sciences Veeva Acquires Ostro to Expand AI-Powered Engagement in Life Sciences (Zacks)
• Positive Sentiment: Analysts collectively maintain a constructive view — Veeva received a consensus rating of “Moderate Buy,” which supports demand for the shares. Veeva Systems Inc. (NYSE:VEEV) Receives Consensus Rating of “Moderate Buy” from Analysts
• Positive Sentiment: Wall Street Zen upgraded VEEV to a Buy, adding to the roster of firms favoring the name after recent execution and AI push. Veeva Systems (NYSE:VEEV) Rating Increased to Buy at Wall Street Zen
• Positive Sentiment: Analyst commentary highlights Veeva as a long‑term growth stock driven by durable SaaS revenue and expanding AI opportunities — supports longer‑term investor theses. Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term
• Neutral Sentiment: Coverage pieces and analyst roundups (e.g., Globe and Mail) provide mixed analyst insights on healthcare software names — useful context but not a direct catalyst. Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Veeva Systems (VEEV) and Janux Therapeutics Inc (JANX)
• Neutral Sentiment: Broader software‑sector commentary notes valuation pressure after recent pullbacks — could cap upside for richly valued SaaS names like Veev despite company‑specific positives. 2 Software Stocks with Solid Fundamentals and 1 We Turn Down
• Negative Sentiment: Some analysts have trimmed fair‑value estimates (example: fair value cut from ~$302.60 to ~$270.93), reflecting more conservative assumptions and creating headwinds for upside if revisions continue. Reframing The Veeva Systems (VEEV) Narrative As Mixed Analyst Views Meet Strong Execution

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Royal Bank Of Canada decreased their price target on shares of Veeva Systems from $330.00 to $275.00 and set an “outperform” rating on the stock in a research note on Thursday, March 5th. Citigroup cut their price objective on Veeva Systems from $319.00 to $291.00 and set a “buy” rating for the company in a research report on Monday, March 9th. William Blair reaffirmed an “outperform” rating on shares of Veeva Systems in a report on Tuesday. The Goldman Sachs Group began coverage on Veeva Systems in a research report on Tuesday, January 13th. They issued a “sell” rating and a $215.00 target price on the stock. Finally, BTIG Research restated a “buy” rating and set a $340.00 price target on shares of Veeva Systems in a report on Friday, November 21st. Seventeen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and an average target price of $283.70.

Veeva Systems Stock Down 1.2%

Veeva Systems stock opened at $178.68 on Friday. The company’s 50-day moving average price is $199.82 and its 200-day moving average price is $243.99. The company has a market cap of $29.37 billion, a PE ratio of 33.03, a price-to-earnings-growth ratio of 1.24 and a beta of 1.09. Veeva Systems Inc. has a twelve month low of $168.13 and a twelve month high of $310.50.

Veeva Systems (NYSE:VEEV) last released its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The firm had revenue of $835.95 million for the quarter, compared to the consensus estimate of $810.95 million. During the same quarter in the previous year, the company posted $1.74 EPS. The company’s revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, sell-side analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Veeva Systems declared that its board has approved a stock buyback program on Monday, January 5th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the technology company to reacquire up to 5.5% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.